Local briefs

A South Carolina woman is dead after a two-vehicle accident in Beulah on Wednesday night.
From: www.pensacolanewsjournal.com

Kids and Asthma: The Best Medicine

Dr. Manny looks at the best ways to treat the symptoms of childhood asthma.
From: www.foxnews.com

Medical: Fight Cancer With Gaming

Nonprofit organization HopeLab joined forces with game developers, cancer experts, psychologists, cell biologists and patients to create a game that could education and entertain young cancer patients.
From: www.addict3d.org

IN BRIEF | Amputee shot by burglar

Crutch comes in handy
From: www.kansascity.com

Video game maker targets teens with cancer

Free Web game is designed to help kids learn better how to beat the disease.
From: www.pcworld.com

Barrier Therapeutics to Present at the FTN Midwest Health Care Conference

Barrier Therapeutics, Inc. (NASDAQ: BTRX), apharmaceutical company that develops and markets dermatology products,today announced that Dr. Geert Cauwenbergh, Chief Executive Officer, willparticipate in the FTN Midwest Health Care Conference.
From: www.sys-con.com

Roche Found Liable in First Of 400 Suits Over Accutane

Roche Holding lost the first of 400 lawsuits claiming its Accutane acne drug causes inflammatory bowel disease when a jury awarded an Alabama man $2.62 million.
From: www.washingtonpost.com

Ranbaxy acquires 13 dermatology products from Bristol-Myers

Ranbaxy Laboratories has acquired the US rights to a group of 13 dermatology products from Bristol-Myers Squibb.
From: www.pharmaceutical-business-review.com

Roche loses $2.6M verdict in Accutane bowel disease suit

TRENTON -- Pharmaceutical company Hoffmann-La Roche on Tuesday lost a $2.6 million jury verdict over Accutane, the first such verdict in a case blaming the severe acne treatment for inflammatory bowel disorder rather than other, more well-known side effects, lawyers say.
From: www.dailyrecord.com

Plaintiff Wins $2.6M From Accutane Maker

Pharmaceutical company Hoffmann-La Roche Inc. was hit Tuesday with a $2.6 million jury verdict over acne treatment Accutane, the first such verdict in a case blaming the drug for inflammatory bowel disorder rather than other, more well-known side effects, lawyers say.
From: biz.yahoo.com

U.S. jury awards $2.5 mln in Roche Accutane trial

A New Jersey jury on Tuesday found that Swiss drugmaker Roche Holding AG failed to adequately warn a patient of the bowel disease risks associated with its acne medicine Accutane and awarded him $2.5 million in damages.
From: news.yahoo.com

Jury awards $2.5 mln in Roche Accutane trial

A New Jersey jury on Tuesday found that Swiss drugmaker Roche Holding AG failed to adequately warn a patient of the bowel disease risks associated with its potent acne medicine Accutane and awarded him $2.5 million in damages.
From: news.yahoo.com

EMEA CMPH Use Adopts 5 Positive Opinions Recommending The Granting Of A Marketing Authorisation For The Following ...

-- Aerinaze (desloratadine 2.5 mg/pseudoephedrine sulphate 120 mg), from Schering-Plough Europe, for the symptomatic treatment of seasonal allergic rhinitis, accompanied by nasal congestion. EMEA review began on 26 July 2006 with an active review time of 196 days. [click link for full article]
From: www.medicalnewstoday.com

Talima Therapeutics Secures $19 Million Series B

Site-specific drug delivery company Talima Therapeutics, Inc. announced today that they have raised $19 million in an oversubscribed second funding round. The funding will allow the company to proceed through Phase II clinical trials.
From: www.redorbit.com

QLT USA Files Aczone Labeling Supplement for Removal of Blood Screening Requirement

Vancouver, BC, May 29, 2007--(T-Net)--QLT (NASDAQ: QLTI; TSX: QLT) announced today that QLT USA, Inc. submitted a labeling supplement (sNDA) for Aczone to the U.S. Food and Drug Administration to request the removal of the gluceose-6-phosphate dehydrogenase screening and blood monitoring requirements from its current label.
From: www.bctechnology.com

Ranbaxy Expands its Presence in the U.S. Dermatology Market Through the Acquisition of 13 Brands from Bristol Myers ...

Ranbaxy Laboratories Inc. , a wholly owned subsidiary of Ranbaxy Laboratories Limited , announced today that it has acquired from Bristol-Myers Squibb Company the U.S. rights to a group of 13 dermatology products.
From: biz.yahoo.com

TM) labeling supplement for removal of blood screening requirement

VANCOUVER, May 29 /PRNewswire-FirstCall/ -- QLT Inc. ( Nachrichten ) (NASDAQ: QLTI; TSX: QLT) announced today that QLT USA, Inc. submitted a labeling supplement (sNDA) for Aczone(TM) to the U.S. Food and Drug Administration (FDA) to request the removal of the gluceose-6-phosphate dehydrogenase (G6PD) screening and blood monitoring requirements from its current label.
From: www.finanznachrichten.de

Ranbaxy acquires US rights for 13 brands

Ranbaxy earned $114 million from its US operations in 2006. It launched 10 new products during the year. The company said that the revenues from the sale of the newly acquired brands would be reflected from the next quarter.
From: www.rediff.com

Ranbaxy buys 13 Bristol brands for $26m

Mumbai, May 28 : Ranbaxy Laboratories has acquired the US brand rights to 13 dermatology products from Bristol-Myers Squibb Company for an estimated consideration of $26 million. The acquisition was made by wholly owned subsidiary Ranbaxy Laboratories Inc.
From: www.telegraphindia.com

Ranbaxy buys rights to sell 13 US drugs

Ranbaxy Laboratories has acquired 13 brands of skin care products from the US pharmaceuticals major Bristol Myers Squibb (BMS). These brands include medication for acne, dermatitis, psoriasis, fungal infections and scabies.
From: www.hindustantimes.com

Ranbaxy buys rights for skin products from BMS for $26 mn

Continuing with its push in the US market, Ranbaxy Laboratories said on Monday it has acquired the marketing rights for 13 skincare products from Bristol-Myers Squibb Company for $26 million.
From: www.rediff.com

Ranbaxy Acquires 13 Brands From Bristol Myers Squibb To Expand Its Presence In US Dermatology Market

(RTTNews) - Monday, Ranbaxy Laboratories Ltd announced that its wholly owned subsidiary, Ranbaxy Laboratories Inc., has acquired the US rights to a group of 13 dermatology products from Bristol-Myers Squibb Company.
From: www.nasdaq.com

Ranbaxy acquires US rights of 13 dermatology products from BMS

Ranbaxy Laboratories Ltd has announced that its wholly owned subsidiary, Ranbaxy Laboratories Inc. (Ranbaxy), has acquired from Bristol-Myers Squibb Company (BMS) the US rights to a group of 13 dermatology products.
From: www.pharmabiz.com

ECZEMA PUTS ME OFF ASKING GIRLS OUT

Q I AM 16 and I have never been out with a girl or even kissed one. I am the only person I know who has not had sex and it is really getting to me. It makes me very depressed.
From: www.dailyrecord.co.uk

Ranbaxy, US buys 13 skin-care brands from BMS

Ranbaxy Laboratories Inc. (Ranbaxy), the wholly owned subsidiary of Ranbaxy Laboratories, has acquired the US rights to a group of 13 dermatology products from Bristol-Myers Squibb (BMS).
From: www.business-standard.com

The magic of Ayurveda

In recent years, Ayurveda has made a comeback all over the world. Is it just another fad or is there more to it?
From: in.news.yahoo.com

Shining light on lasers

Therapy heals skin and more
From: torontosun.com

Laser resurfacing: Effective wrinkle treatment

Laser resurfacing treats wrinkles and minor facial flaws, but it does have limitations. Is this procedure your best bet for skin rejuvenation?
From: www.mayoclinic.com

Quest PharmaTech announces financial and operational results for the fiscal year ended January 31, 2007

Quest PharmaTech Inc. announces the highlights of financial and operational results of the fiscal year ended January 31, 2007 .
From: biz.yahoo.com

DUSA Pharmaceuticals to Present at the Friedman, Billings, Ramsey & Co., Inc. 2007 Growth Conference

DUSA Pharmaceuticals, Inc. announced today that it will present at the Friedman, Billings, Ramsey & Co., Inc. 2007 Growth Conference. The presentation is scheduled for 3:50 p.m. EDT on Wednesday, May 30th at the Grand Hyatt Hotel in New York, NY.
From: biz.yahoo.com

EGFRIs)

Skin reactions to a powerful new class of anti-cancer drugs are frequent, but manageable through a simple and rational treatment approach , usually without the need to reduce the dose or interrupt treatment with potentially life-prolonging chemotherapy, according to an article in the May issue of "The Oncologist."
From: www.news-medical.net

Tate Times Drawing Challenge shortlist

You were interested in your acne and how your hair looked. We were interested in honesty, courage and lack of self-consciousness. And on Monday our mutual concerns met.
From: www.timesonline.co.uk

Barrier Therapeutics to Present at the Bank of America 2007 Health Care Conference

Barrier Therapeutics, Inc. (NASDAQ: BTRX), apharmaceutical company that develops and markets dermatology products,today announced that Dr. Geert Cauwenbergh, Chief Executive Officer, willparticipate in the Bank of America 2007 Health Care Conference.
From: www.sys-con.com

Sciton Announces ProFractional Launch During ASLMS

PALO ALTO, Calif., April 17 // -- Sciton, the leader in laser resurfacing technologies, announced during the American Society for Laser Medicine and Surgery (ASLMS), in Grapevine, Texas, the launch of the new ProFractional laser technology. ProFractional employs the robotically scanned Contour laser from Sciton to deliver micro-ablation channels deep into the dermis. The resulting new collagen ...
From: news.thomasnet.com

Hypothyroidism and Hyperlipidemia With a Virilizing Ovarian Steroid Cell Tumor, Not Otherwise Specified

By Tsai, Horng-Jyh; Chen, Shu-Chen; Wei, Hsiao-Yun; Chen, Gin-Den Abstract Steroid cell tumors, not otherwise specified, are rare ovarian sex cord-stromal tumors with malignant potential. The majority of these tumors produce steroids, with testosterone being the most common.
From: www.redorbit.com

Pimple Treatment And Causes

What Are Pimples And How Do I Fight Them? Pimples are small skin lesions or inflammations of the skin. They are commonly caused by clogged or infected pores. Pimples usually develop after blackheads or whiteheads have become infected. When breakouts of pimples occur often, it is considered acne. [click link for full article]
From: www.medicalnewstoday.com

Pioneering Skin Researchers At The University Of Leeds Achieve International Quality Standard, UK

The Skin Research Centre at the University of Leeds, which has led the way in the treatment of acne, eczema and other skin conditions, is the only University skin microbiology laboratory in the UK to receive the international quality standard ISO 17025. [click link for full article]
From: www.medicalnewstoday.com

Pioneering skin researchers at the University of Leeds achieve international quality standard

The Skin Research Centre at the University of Leeds, which has led the way in the treatment of acne, eczema and other skin conditions, is the only University skin microbiology laboratory in the UK to receive the international quality standard ISO 17025.
From: www.news-medical.net

The future of contraception

New developments in contraception may mean changes to the method and the means of contraception.
From: thedaily.washington.edu

Acne Treatment Diagnosis And Numbers

Most people develop acne at some point in their lives. Normally, acne occurs during adolescence, when hormone changes are at their peak. Acne is also commonly seen in women during premenstrual or menopausal periods. Acne occurs in any race, age, gender, social status or lifestyle. [click link for full article]
From: www.medicalnewstoday.com

Business briefs: May 23

One of Marco?s top Realtors for the past decade, Pat Wilkins, recently attended an ?elite Realtors? conference hosted by CKG International, an internationally recognized real estate coaching firm to the world?s most successful agents.
From: www.marconews.com

Benzoyl Peroxide And Acne

Benzoyl Peroxide is commonly used to treat mild acne topically. It consists of two parts benzoyl and one part peroxide. It is a strong bleaching agent, therefore when applied to hair or fabrics, can be decolorized immediately. Benzoyl peroxide has three basic properties. It can be used as an effective antiseptic, an oxidizing agent or as an anti-inflammatory. [click link for full article]
From: www.medicalnewstoday.com

First Painless Laser Treatment for Acne Introduced

Aesthera Corporation, the pioneer of technologically advanced PhotopneumaticTM (PPx) aesthetic systems, announced today the arrival of its newest painless laser therapy - Isolaz - into the consumer marketplace.
From: biz.yahoo.com

Look beautiful at any age

Is beauty a matter of genetics, age, maintenance or sneaky tricks? A little of each, it turns out. While there are basics (confidence, a sense of humor, a good sunscreen), a few special style secrets can help.
From: www.northjersey.com

Nigeria: Microderm Abrasion

Microdermabrasion is a procedure performed by a medical doctor or trained aesthetician where the topmost layer of skin is buffed away thus improving its texture and tone. This treatment improves the appearance of superficial wrinkles and skin irregularities leaving the skin supple and more vibrant.
From: allafrica.com

The butt facial - the new fad

Worried about being the butt of jokes when you get in your swimsuit or gym gear?
From: www.chinadaily.com.cn

Protein treatment offers hope to baldies

Scientists have for the first time found a way to regenerate hair follicles which may lead to a cure for baldness - and a bonanza for its inventors.
From: www.nzherald.co.nz

TM) Fractional Treatment Applicator for Wrinkle Treatment

Syneron Medical Ltd. (NASDAQ: ELOS), an innovator in the development, marketing and sales of elos(TM)combined-energy medical aesthetic devices, today introduces the new MatrixIR(TM), an elos fractional applicator for use with its eMax(TM) andeLaser(TM) systems.
From: www.sys-con.com

Herborium Group Announces Acquisition Strategy

TEANECK, N.J.----Herborium Group, Inc. , a developer and marketer of novel botanical therapeutics®, including its successful Acne and Rosacea treatment , announced today that it has narrowed its acquisition targets to two companies engaged in developing and marketing proprietary, clinically tested Traditional Chinese Medicinal formulations.
From: biz.yahoo.com

R) PDT to Treat Esophageal Dysplasia

DUSA Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation for Levulan® Photodynamic Therapy for the treatment of esophageal dysplasia.
From: biz.yahoo.com

Miracle Skin Cream or Marketing Genius?

Consumers Clamor for New Skin Care Cream, but Is It Worth the Hype?
From: abcnews.go.com

Acne-treatment company scores $9 million in funding

Therative Inc., which unveiled its ThermaClear acne treatment device in February, said Wednesday it has closed a new round of private financing that raised $9 million.
From: www.bizjournals.com

CollaGenex Pharmaceuticals and QuatRx Pharmaceuticals Announce Agreement for the Development and Commercialization of ...

NEWTOWN, Pa. & ANN ARBOR, Mich.----CollaGenex Pharmaceuticals, Inc. and QuatRx Pharmaceuticals Company today announced a licensing agreement under which CollaGenex will develop and commercialize becocalcidiol, a patented Vitamin D analogue developed by QuatRx that is currently in Phase II clinical trials for the topical treatment of mild to moderate psoriasis.
From: biz.yahoo.com

Polycystic Ovary Syndrome)

Project PCOS announced The One Million for PCOS Campaign today to provide, more services, support and awareness for polycystic ovary syndrome. (PRWeb May 16, 2007) Post Comment:Trackback URL: http://www.prweb.com/pingpr.php/Q291cC1TcXVhLU1hZ24tRW1wdC1UaGlyLVplcm8=
From: prweb.com

Consumers Welcome Relief From Acne; ThermaClear Gains Market Acceptance

Therative Closes Series C Funding and Plans Market Expansion (PRWeb May 16, 2007) Post Comment:Trackback URL: http://www.prweb.com/pingpr.php/SW5zZS1TdW1tLUxvdmUtRW1wdC1UaGlyLVplcm8=
From: prweb.com

At-Home Spa Treatments Available

New technology is allowing people to do medical spa-quality treatments at home.
From: www.nbc5i.com

Do-it-yourself cosmetic lasers worry doctors

Last year, more than 11-million cosmetic procedures were performed in this country and 80-percent of them were non-surgical. Now many people have found a way to revitalize skin, without the expense, in the comfort of their own home.
From: www.fox11az.com

Action News Extra: New Treatment For Acne Scars, Stretch Marks, More

The following is a transcript of a report by anchor Kelly Frey that first aired May 14, 2007, on WTAE Channel 4 Action News at 5 p.m.
From: news.yahoo.com

Hercules Provides $10 Million Financing to Early-Stage Neosil, a Pharmaceutical Company Developing Dermatological ...

PALO ALTO, Calif.----Adding a dermatology focused pharmaceutical company to its portfolio, Hercules Technology Growth Capital, Inc. , a leading specialty finance company providing growth capital to venture capital and private equity backed technology and life science companies, today announced that on May 2, 2007 it provided $10 million of venture debt financing to Neosil, Inc.
From: biz.yahoo.com

Action News Extra: New Treatment Out For Acne Scars, Stretch Marks, More

The following is a transcript of a report by anchor Kelly Frey that first aired May 14, 2007, on WTAE Channel 4 Action News at 5 p.m.
From: news.yahoo.com

Non-invasive is in

EARLY THIS YEAR, Thermage International cited celebrity doctor Vicki Belo of the Belo Medical Group for having had the most number of Thermage patients in the world in 2006, ahead of some 2,000 cosmetic surgeons from the United States, Europe and Asia.
From: showbizandstyle.inquirer.net

Syneron Reports 36% Increase in First Quarter 2007 Results to $32.3 Million

Syneron Medical Ltd., an innovator in the development, marketing and sales of elos(TM) combined-energy medical aesthetic devices, today reported financial results for the first quarter of 2007, and, in a separate announcement, changes to the management structure to support the long-term growth strategy of the Company.
From: biz.yahoo.com

Don?t turn red; fight off rosacea with lights, lotion

You don?t have to cover up. There are ways to fight some common skin ailments. Often caused by acne, broken capillaries, sunburn, stress, diet or the result of a cosmetic procedure like a facial or chemical peel, redness in the skin is the body?s way of sending a message that it is fighting inflammation and irritation from within.
From: www.fortwayne.com

Costs, downtime vary or nonsurgical methods

Here are the most common noninvasive procedures for rejuvenation: TOPICAL TREATMENTS Prescription skin products such as Renova and Retin-A...
From: seattletimes.nwsource.com

Tyrell Donates $15,000 to M. D. Anderson

Tyrell, Inc., the creators of Zeno, an innovative handheld medical device used in the treatment of acne, presented a check for $15,000 to M. D. Anderson. The product that made this donation possible is one of the newest additions to the Zeno product line -- Zeno PRO.
From: biz.yahoo.com

QPC Ships 2,000th Varicose Vein Treatment Laser

SYLMAR, Calif.----QPC Lasers, Inc. "QPC," today announced that it has shipped to a leading medical equipment manufacturer its 2,000th high-brightness semiconductor laser used for varicose vein treatment.
From: biz.yahoo.com

Syntopix in trials for acne treatment

SYNTOPIX, the Yorkshire-based drug development company, has signed an agreement with German research organisation Bioskin to conduct trials to discover possible cosmetic treatments for acne. (09/05/2007 09:00:19)
From: www.yorkshiretoday.co.uk

15 minutes with a dermatologist

People spend many hours and lots of money trying to fix acne, wrinkles and red spots. Dermatologist Jonathan Gold, who practices in Clifton, talks about common skin problems and how to solve them.
From: www.northjersey.com

Options to living with acne scars

Red or depressed acne scars are more than a physical reminder of past breakouts. They impact our self-esteem and how we are perceived by others. Depending on the severity of the scarring, there are a variety of treatment options that can help restore your skin to a smooth, even state.
From: www.bonitanews.com

TM) Laser System

SAN DIEGO----Reliant Technologies, Inc., the pioneer of fractional resurfacing and market leader of aesthetic laser skin treatments, today announced that it has received FDA clearance for the Fraxel re:fine laser system.
From: biz.yahoo.com

Drospirenone/Ethinyl Estradiol) for ...

Bayer HealthCare Pharmaceuticals Inc., a U.S.-based pharmaceuticals unit of Bayer HealthCare, and Intendis Inc., a U.S.-based affiliate of Bayer Schering Pharma AG, Germany, announced today that they will jointly promote YAZ® as a treatment for moderate acne in women who desire an oral contraceptive for birth control.
From: biz.yahoo.com

CollaGenex Pharmaceuticals Discontinues 40 mg Cohort of Phase II Dose-Finding Study of Incyclinide for the Treatment of ...

NEWTOWN, Pa.----CollaGenex Pharmaceuticals, Inc. today announced that it has discontinued treatment of all enrolled patients participating in the 40 mg cohort of its Phase II dose-finding study of incyclinide for the treatment of acne.
From: biz.yahoo.com

New Products: Aquafina Adds Beauty SKUs To Enhance Liquid Assets

PepsiCo water division enters cosmetic category to boost brand. May 07, 2007 By Becky Ebenkamp
From: brandweek.com

CollaGenex Stops Treatment in Acne Trial

CollaGenex Pharmaceuticals Inc., a developer of skin treatments, said Monday it stopped treating a group of acne patients in a mid-stage clinical study after a second patient was found to be overly sensitive to sunburn.
From: biz.yahoo.com

Best Skin Care Product Institute Launches 10-Step Acne Treatment Program

A Leader in Anti Aging Skin care, Donna Tozzi unveils her mask. Pitch the Pimple Creams and start the Tozzi medical grade Acne Treatment Regimen (PRWeb May 7, 2007) Post Comment:Trackback URL: http://www.prweb.com/pingpr.php/TG92ZS1Mb3ZlLUVtcHQtRW1wdC1UaGlyLVplcm8=
From: prweb.com

Proscar) on Acne and Alopecia in Female Patients With Normal Serum Levels of Free ...

By Kohler, Claudia; Tschumi, Katharina; Bodmer, Christine; Schneiter, Martin; Birkhaeuser, Martin Abstract Background.
From: www.redorbit.com

Medical Crystal Ball: Genetic Tests Can Open the Door to Predicting Your Future Health

If you could take a test to tell you what disea
From: www.redorbit.com

CollaGenex suspends patient enrollment in acne trial

CollaGenex Pharmaceuticals has suspended enrollment in a phase II dose-finding study incyclinide for the treatment of acne after one patient experienced significant phototoxicity.
From: www.pharmaceutical-business-review.com

CollaGenex shares drop after acne-drug-test result

Shares of CollaGenex Pharmaceuticals Inc. fell 18.5 percent yesterday after the Newtown company said it suspended enrollment in a mid-stage study of a new acne drug after one patient experienced a severe adverse reaction.
From: www.philly.com

Check Into the Zit Clinic

"I need to get cleaned up!"
From: abclocal.go.com

Soothing spring water

Finding skin care products and cosmetics can be frustrating if you have sensitive or problem skin. Using unsuitable products could result in rashes, breakouts or irritated, scaly skin.
From: thestar.com.my

CollaGenex Posts Narrower 1Q Loss

CollaGenex Pharmaceuticals Inc., which develops skin treatments, said Wednesday it trimmed its first-quarter loss due to increased revenue, but shares slipped after the company suspended enrollment in an acne trial because of an adverse event.
From: biz.yahoo.com

Auriga Laboratories Appoints Steven D. Gallopo As Vice President of Business Development

Auriga Laboratories, Inc. (OTCBB:ARGA), a specialty pharmaceutical company with products for the treatment of Xerostomia, dermatological conditions, and acute respiratory diseases, announced today that it has appointed Steven D. Gallopo as its Vice President of Business Development. Mr.
From: www.redorbit.com

CollaGenex Halts Trial on Adverse Event

CollaGenex Pharmaceuticals Inc., which develops skin treatments, said Wednesday it suspended enrollment in a mid-stage acne treatment study to investigate an adverse reaction to the medication.
From: biz.yahoo.com

CollaGenex Pharmaceuticals Provides Update on 40 mg Cohort of Phase II Dose-Finding Study of Incyclinide for the ...

NEWTOWN, Pa.----CollaGenex Pharmaceuticals, Inc. today announced that it has learned that one patient has experienced apparent significant photo-toxicity, a known side effect of tetracyclines, while participating in the 40 mg cohort of its Phase II dose-finding study of incyclinide for the treatment of acne.
From: biz.yahoo.com

Barrier Therapeutics to Release First Quarter 2007 Financial Results on May 10, 2007

Barrier Therapeutics, Inc., a pharmaceutical company developing and commercializing products in the field of dermatology, is scheduled to release financial results for the first quarter of 2007 on Thursday, May 10, 2007 at approximately 4:00 p.m.
From: biz.yahoo.com

CollaGenex Pharmaceuticals Reports Financial Results for the First Quarter of 2007

NEWTOWN, Pa.----CollaGenex Pharmaceuticals, Inc. today reported financial results for the quarter ended March 31, 2007. Total revenues for the first quarter of 2007 were approximately $14.3 million, including $11.1 million in net sales of Oracea®, compared to approximately $3.7 million in the first quarter of 2006, which included no sales of Oracea.
From: biz.yahoo.com

Cipher reports first quarter fiscal 2007 results

Cipher Pharmaceuticals Inc. today announced its financial and operational results for the three months ended March 31, 2007.
From: biz.yahoo.com

Fytokem announces record sales in 2006

Fytokem Products Inc. , today announced its financial results for the year ended December 31, 2006. Fytokem posted record sales of $860,000 for 2006, up by 31% over 2005. This continues a growth trend that has seen sales grow by an average of 22% annually over the past three years.
From: biz.yahoo.com

Herborium Grows its Management Team with Industry Experts

TEANECK, N.J.----Herborium Group, Inc. , a developer and marketer of novel botanical therapeutics®, including successful Acne and Rosacea treatment announced today that it has appointed Mr.
From: biz.yahoo.com

DUSA Pharmaceuticals, Inc. to Host First Quarter Financial Results and Corporate Highlights Conference Call

DUSA Pharmaceuticals, Inc. announces that its corporate highlights and first quarter financial results press release will be issued on May 4, 2007 at 6:30 a.m. to be followed by a conference call at 8:30 a.m.
From: biz.yahoo.com

Doctor: New Acne Treatment Unique

One acne sufferer says a new acne treatment made her skin look better in 24 hours.
From: www.nbc5i.com